JOSHUA NDEMATEBEM: Open Payments
NPI 1407484181 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 60 payments from 11 companies in 2025. Trend: 2023 $464 · 2024 $748 · 2025 $1,165
Food & beverage: $1,153Travel & lodging: $12
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $260 |
| Neurocrine BioSciences, Inc. | 9 | $230 |
| Janssen Pharmaceuticals, Inc | 3 | $187 |
| ABBVIE INC. | 23 | $184 |
| Supernus Pharmaceuticals, Inc. | 3 | $151 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Alkermes, Inc. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Indivior Inc. | 1 | $15 |
Products named: COBENFY, INGREZZA, VRAYLAR, SPRAVATO, Qelbree, Auvelity, REXULTI, ARISTADA.
Industry payments across OH — which companies pay providers there.
